Drax Group (DRX) Trading Update summary
Event summary combining transcript, slides, and related documents.
Trading Update summary
6 Jun, 2025Financial performance and outlook
Strong operational performance in FlexGen, Pellet Production, and Biomass Generation, with 2025 Adj. EBITDA expected at the top end of consensus (£848–896m).
Targeting post-2027 recurring Adj. EBITDA of £600–700 million, reflecting confidence in long-term earnings.
£300 million share buyback program underway, with £207 million completed and further tranches planned.
Final 2024 dividend of 15.6p per share proposed, total 2024 dividend up to 26.0p (2023: 23.1p).
Over £2 billion in contracted forward power sales for 2025–2027, with RO generation fully hedged for 2025 and 90% for 2026.
Operational updates and projects
£80 million refurbishment at Cruachan Power Station progressing, adding 40MW by 2027 under a 15-year Capacity Market agreement.
Cruachan II 600MW expansion design completed, but Drax will not participate in the first phase of the cap and floor scheme due to cost and risk concerns.
Commissioning of three new OCGTs (c.900MW) expected in 2025, delayed by grid connection issues.
Secured new Capacity Market agreements for 434MW (2028–2029) and 24MW (Glenlee refurbishment, 2028–2043), extending contracted earnings visibility to 2043.
Business development and sustainability
Sale of Opus Energy SME customer meter points agreed, focusing Energy Solutions on core I&C and renewables services.
Pellet Production business performing ahead of 2024, aided by favorable weather.
Drax Power Station continues to provide reliable renewable power, with no major outages planned for 2025.
Entered a 20-year JV with Power Minerals Limited to process and sell PFA for low-carbon cement, expected to reduce emissions by at least 6Mt and add c.£5m Adj. EBITDA post-2027.
Latest events from Drax Group
- Record renewable output, robust cash flow, and major BESS investments drive 2025 strategy.DRX
H2 202526 Feb 2026 - Adjusted EBITDA up 24% to £515m, net debt down, and £300m buyback to begin Q3 2024.DRX
H1 20242 Feb 2026 - Upgraded post-2027 EBITDA target, record financials, and robust outlook from renewables.DRX
H2 202417 Dec 2025 - 2025 Adj. EBITDA set to exceed expectations, supporting major growth and shareholder returns.DRX
Trading Update11 Dec 2025 - Strong H1-25 results, buyback extension, and new CfD terms boost long-term earnings outlook.DRX
H1 202531 Jul 2025 - Strong 2024 performance, strategic growth in BECCS and renewables, and robust capital returns.DRX
Trading Update13 Jun 2025 - Drax expects 2025 Adj. EBITDA at the top end of consensus, driven by strong operations and contracts.DRX
Q1 20256 Jun 2025